EPCAM and cervical cancer: All of these results suggested that SNAI2 blocked the nuclear translocation of β-catenin by inhibiting EPCAM expression, further suppressing the expression of c-Myc and SOX2, and ultimately attenuating the stem-like phenotype in cervical cancer cells.